Systematic Multi-Arm Adaptive Randomised Trial is a PHASE2 clinical asset sponsored by University of Edinburgh in Motor Neuron Disease, Amyotrophic Lateral Sclerosis. SEO and diligence focus: Memantine Hydrochloride Oral Solution, Trazodone Hydrochloride oral solution, Placebo oral solution, Amantadine Hydrochloride Oral Solution, Tacrolimus 1Mg Cap, Placebo capsule, endpoint relevance, enrollment feasibility, competitive positioning, readout timing and IP durability.